Amarin Corporation

Amarin Corporation ROCE

The Return on Capital Employed (ROCE) of Amarin Corporation (AMRN) as of Nov 5, 2026 is -3.04 %. In the previous year, Return on Capital Employed (ROCE) was -18.88 % — a change of -83.92% (higher).

ROCE

-3.04 %

YoY

-83.92%

Last updated:

In 2025, Amarin Corporation's return on capital employed (ROCE) was -3.04 %, a -83.92% increase from the -18.88 % ROCE in the previous year.

The Amarin Corporation ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-71.26 USD
Jan 1, 2019
-3.99 USD
Jan 1, 2020
-3.13 USD
Jan 1, 2021
1.57 USD
Jan 1, 2022
-17.78 USD
Jan 1, 2023
-10.25 USD
Jan 1, 2024
-18.88 USD
Jan 1, 2025
-3.04 USD
The Amarin Corporation ROCE history
YEARROCEYoY
-3.04 %-83.92%
-18.88 %+84.12%
-10.25 %-42.33%
-17.78 %-1,229.61%
1.57 %-150.26%
-3.13 %-21.53%
-3.99 %-94.40%
-71.26 %-200.70%
70.77 %-88.94%
639.63 %+741.31%
76.03 %-29.92%
108.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Amarin Corporation's Return on Capital Employed (ROCE)

Amarin Corporation's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Amarin Corporation's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Amarin Corporation's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Amarin Corporation’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Amarin Corporation stock

Return on Capital Employed (ROCE) of Amarin Corporation is -3.04 % in 2025.

Return on Capital Employed (ROCE) of Amarin Corporation changed from -18.88 % to -3.04 %, representing a -83.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Amarin Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Amarin Corporation

All Key Metrics — Amarin Corporation